QA: Greenwich LifeSciences Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001799788_2023_Greenwich_LifeSciences_Inc.pdf

Logs

Graph

Absolute values for 0001799788, Greenwich LifeSciences Inc.

  xvar xval
0 AssetsCurrent 0
1 IntangibleAssetsNetIncludingGoodwill 9,003
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 13,468,026
4 LiabilitiesCurrent 262,905
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 1,564,586
9 ResearchAndDevelopmentExpense 6,475,668
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 215,017
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 13,477,029
1 Liabilities 262,905
2 Expenses 8,040,254
3 Revenues 0
4 StockholdersEquity 13,214,124
5 NetIncome -7,825,237
6 ComprehensiveNetIncome -7,825,237
7 BaseVar 10,997,602
8 EconomicCapitalRatio 2.17

Edgar->Model Mapping

Feature Distribution

Change over Time